IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.
about
Overcoming tumor immune evasion with an unique arbovirusPotential clinical application of interleukin-27 as an antitumor agent.The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.IL-27 induces the expression of IDO and PD-L1 in human cancer cells.Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.Administration of DNA Encoding the Interleukin-27 Gene Augments Antitumour Responses through Non-adaptive Immunity.Therapeutic potential of interleukin-27 against cancers in preclinical mouse models.Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.
P2860
Q28081774-1A5774CD-2446-4FCB-AD1C-D31409F7E3EDQ34483131-2EB5E1EE-44EB-4DEC-9CC5-1F4F66389011Q35166971-9DFF4959-5C51-4447-880F-85F472730E87Q36685395-9FF0C175-40C9-4231-9D1B-97748B68AE1EQ36879787-B6883ABB-15A4-4C5C-9988-3BBA6B4AF546Q39158943-3789FAE2-EFD7-465E-866A-4BF5DED58953Q39377049-90F14CB6-CBEC-467E-917E-8C151DF21743Q40814716-B0D61D4A-2676-425C-8C2E-3962CAAEE5D0Q41578456-F62FCF42-E77C-4A02-A1BF-507EC961EE39Q51279715-52210EB0-D4D9-485D-92CA-6E29E567DA7CQ52738926-06AAE5C0-5101-4CF2-AEB8-26E28F9BD388
P2860
IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@ast
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@en
type
label
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@ast
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@en
prefLabel
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@ast
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@en
P2093
P2860
P1433
P1476
IL-27 enhances the expression ...... y in a TRAIL-dependent manner.
@en
P2093
Chikako Nishigori
Hiroshi Nagai
Izuru Mizoguchi
Junichiro Mizuguchi
Kana Mitobe
Kaname Higuchi
Takayuki Yoshimoto
Yukino Chiba
P2860
P304
P356
10.1371/JOURNAL.PONE.0076159
P407
P577
2013-10-14T00:00:00Z